Mind the Gap: Statin Underutilization and Impact on Mortality in Liver Transplant Recipients
Liver transplant (LT) recipients are at a substantially increased risk of cardiovascular disease compared due to accelerated development and progression of hypertension, diabetes, obesity and dyslipidemia. 1 As a result, cardiovascular disease is a leading cause of morbidity and mortality post-LT. 2...
Gespeichert in:
| Veröffentlicht in: | Liver transplantation 2019-10, Vol.25 (10), p.1477-1479 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Liver transplant (LT) recipients are at a substantially increased risk of
cardiovascular disease compared due to accelerated development and progression
of hypertension, diabetes, obesity and dyslipidemia.
1
As a result, cardiovascular disease is a
leading cause of morbidity and mortality post-LT.
2
This is in spite of aggressive
pre-transplant evaluation for prevalent cardiovascular disease, in particular
coronary artery disease (CAD), and exclusion of very high-risk patients from LT.
However the commonest causes of early ( |
|---|---|
| ISSN: | 1527-6465 1527-6473 1527-6473 |
| DOI: | 10.1002/lt.25627 |